Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1482.30 -10.40 (-0.70%) | NSE 1482.10 -9.50 (-0.64%) | Trade | Add

BSE Live

Feb 18, 11:29

1482.30 -10.40 (-0.70%)

Volume

AVERAGE VOLUME

5-Day

15,201

10-Day

51,209

30-Day

47,639

2,508

Prev. Close

1492.70
Open Price

1481.25

Bid Price (Qty.)
1482.00 (10)
Offer Price (Qty.)
1484.00 (13)

NSE Live

Feb 18, 11:29

1482.10 -9.50 (-0.64%)

Volume

AVERAGE VOLUME

5-Day

269,131

10-Day

199,101

30-Day

238,264

25,475

Prev. Close

1491.60
Open Price

1491.00

Bid Price (Qty.)
1482.00 (99)
Offer Price (Qty.)
1483.40 (2)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ipca Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.37	25.37	25.37	25.37	25.37
Total Share Capital	25.37	25.37	25.37	25.37	25.37
Reserves and Surplus	6,923.08	6,306.82	5,816.65	5,466.60	4,676.28
Total Reserves and Surplus	6,923.08	6,306.82	5,816.65	5,466.60	4,676.28
Total Shareholders Funds	6,948.45	6,332.19	5,842.02	5,491.97	4,701.65
Minority Interest	1,439.82	1,394.81	73.30	76.92	14.53
NON-CURRENT LIABILITIES
Long Term Borrowings	543.24	580.41	651.78	395.18	9.13
Deferred Tax Liabilities [Net]	294.97	310.47	189.16	152.58	133.55
Other Long Term Liabilities	51.54	40.92	17.36	13.60	10.40
Long Term Provisions	96.31	86.84	46.99	42.73	38.56
Total Non-Current Liabilities	986.06	1,018.64	905.29	604.09	191.64
CURRENT LIABILITIES
Short Term Borrowings	758.46	807.09	805.75	396.06	243.21
Trade Payables	846.17	776.08	525.06	557.70	664.86
Other Current Liabilities	512.42	527.91	366.98	410.60	149.33
Short Term Provisions	269.17	244.56	108.03	101.52	103.14
Total Current Liabilities	2,386.22	2,355.64	1,805.82	1,465.88	1,160.54
Total Capital And Liabilities	11,760.55	11,101.28	8,626.43	7,638.86	6,068.36
ASSETS
NON-CURRENT ASSETS
Tangible Assets	4,068.91	4,339.51	2,572.41	2,208.75	1,962.79
Intangible Assets	107.06	123.30	140.83	154.61	63.04
Capital Work-In-Progress	616.17	323.59	122.17	293.85	183.66
Fixed Assets	4,798.00	4,805.84	2,853.67	2,669.79	2,260.65
Non-Current Investments	216.32	303.61	302.66	269.88	111.43
Deferred Tax Assets [Net]	16.92	4.23	3.57	2.02	1.95
Long Term Loans And Advances	32.35	88.59	115.90	71.40	139.47
Other Non-Current Assets	337.84	269.53	123.22	114.44	71.30
Total Non-Current Assets	5,492.01	5,562.38	3,437.16	3,181.69	2,631.40
CURRENT ASSETS
Current Investments	763.39	558.40	323.32	719.31	393.83
Inventories	2,560.42	2,471.31	1,743.37	1,857.97	1,594.81
Trade Receivables	1,873.82	1,686.51	989.02	910.78	811.75
Cash And Cash Equivalents	344.23	296.84	1,853.24	640.66	365.07
Short Term Loans And Advances	42.76	9.40	3.23	10.34	2.47
OtherCurrentAssets	683.92	516.44	277.09	318.11	269.03
Total Current Assets	6,268.54	5,538.90	5,189.27	4,457.17	3,436.96
Total Assets	11,760.55	11,101.28	8,626.43	7,638.86	6,068.36
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	613.89	303.44	2,125.64	274.03	369.48
BONUS DETAILS
Bonus Equity Share Capital	10.45	10.45	10.45	10.45	20.90
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	219.14	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	182.55	146.59	172.85	155.19	34.17
CURRENT INVESTMENTS
Current Investments Quoted Market Value	763.39	558.40	323.32	719.31	393.83
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00